data_1op4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1op4 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.252 0.549 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -170.28 31.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 110.373 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 m -128.27 -41.24 1.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.451 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.07 110.93 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.413 ' CG ' HG22 ' A' ' 29' ' ' ILE . 5.0 tt0 -133.08 -78.77 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -1.122 . . . . 0.0 110.146 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 29' ' ' ILE . 26.6 pt -135.78 174.23 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.206 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.75 19.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 110.476 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 145.33 24.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.388 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.76 140.4 42.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 110.346 179.863 -157.878 -166.278 129.073 104.186 2.021 104.228 128.797 -151.184 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.02 93.49 4.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.502 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 m -74.05 125.5 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.263 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 115' ' ' TRP . . . 128.5 -163.61 21.94 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.438 ' CE2' HG12 ' A' ' 117' ' ' VAL . 23.4 m-85 -85.6 160.19 53.95 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.282 -1.128 . . . . 0.0 109.922 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -86.81 33.7 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.597 1.314 . . . . 0.0 111.681 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.11 42.6 30.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.943 -1.098 . . . . 0.0 110.699 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -132.22 -159.21 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 110.003 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -141.45 151.72 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.094 -1.004 . . . . 0.0 110.543 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' CE2' HG23 ' A' ' 117' ' ' VAL . 22.7 m-85 -111.18 157.6 19.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.662 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.32 123.74 32.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.01 -1.057 . . . . 0.0 111.012 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 121' ' ' LEU . . . -109.68 136.28 49.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.472 -0.767 . . . . 0.0 109.674 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.16 139.9 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 0.0 110.979 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.433 ' CD2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -131.38 152.21 80.12 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.545 -0.722 . . . . 0.0 109.517 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.433 ' HD2' ' CD2' ' A' ' 45' ' ' LEU . 18.6 Cg_endo -63.53 -15.75 50.47 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.467 1.246 . . . . 0.0 111.266 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 53.4 27.04 5.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.278 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.48 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 34.2 m-20 -121.71 32.56 5.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.154 -0.966 . . . . 0.0 110.388 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.3 t 63.34 36.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.247 -0.908 . . . . 0.0 110.649 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 48' ' ' ASP . 6.4 m-70 -96.22 121.64 38.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.004 -1.06 . . . . 0.0 110.164 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 17.6 mt-10 -84.68 -174.77 5.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.358 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 54.8 42.49 79.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 73.7 mm-40 -70.89 163.2 66.95 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.429 -1.042 . . . . 0.0 111.109 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.18 175.84 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.99 1.521 . . . . 0.0 112.367 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 88' ' ' TYR . 26.4 mt -113.58 129.83 56.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.768 -0.583 . . . . 0.0 110.349 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.509 ' CD2' ' CG1' ' A' ' 87' ' ' VAL . 1.2 tt -91.96 151.74 20.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.604 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 44.6 t-20 -128.32 122.04 30.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.916 . . . . 0.0 110.731 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 85' ' ' GLY . 30.0 m -86.34 153.9 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.178 -0.951 . . . . 0.0 109.819 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 62.66 2.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 110.763 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.459 ' CE1' ' HA2' ' A' ' 35' ' ' GLY . 76.1 t80 -57.68 120.64 8.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.982 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -68.78 128.16 35.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 110.065 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.28 158.96 15.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 110.788 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.419 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 2.0 t -174.11 -178.09 1.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.488 -0.758 . . . . 0.0 109.921 179.703 -151.184 128.797 129.073 104.228 2.021 104.186 -166.278 -157.878 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.12 -144.5 0.65 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.062 -1.024 . . . . 0.0 110.051 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -142.56 124.6 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.904 -1.122 . . . . 0.0 110.655 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 57.79 115.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.537 -0.727 . . . . 0.0 111.088 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.419 ' NE ' ' O ' ' A' ' 63' ' ' CYS . 1.8 ptp85 -156.91 70.43 0.63 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 110.367 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -68.47 114.96 7.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.022 -1.049 . . . . 0.0 110.112 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 12.0 m -108.56 165.53 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 110.415 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -92.63 144.83 24.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.199 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.484 ' CD2' ' HA ' ' A' ' 83' ' ' GLU . 37.9 m-85 -122.37 157.61 31.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.714 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.69 141.65 22.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.378 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.427 ' HB3' ' CG1' ' A' ' 81' ' ' VAL . 5.0 p -110.6 171.52 7.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -0.923 . . . . 0.0 110.455 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 t -159.35 35.73 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.482 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.483 ' HG3' ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -92.63 144.6 28.94 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.342 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -50.91 -55.55 3.96 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.581 1.306 . . . . 0.0 110.503 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.32 -156.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.75 125.64 50.35 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.372 -0.83 . . . . 0.0 109.595 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 8.4 m-85 -132.13 149.78 52.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.945 -1.097 . . . . 0.0 110.765 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 88' ' ' TYR . 16.9 mttt -129.61 111.94 13.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.634 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 73' ' ' SER . 33.6 m -86.75 116.68 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.442 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.91 137.94 31.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.256 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 71' ' ' TYR . 4.1 mt-10 -46.64 -26.76 0.97 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.569 -0.707 . . . . 0.0 110.973 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.68 -11.85 48.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 110.518 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.435 ' O ' ' CG2' ' A' ' 58' ' ' VAL . . . 98.65 31.11 6.51 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 8.4 p -122.4 112.89 18.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.235 . . . . 0.0 111.121 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.509 ' CG1' ' CD2' ' A' ' 56' ' ' LEU . 11.8 p -96.11 122.28 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.946 -1.096 . . . . 0.0 108.898 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.482 ' CD1' ' HB3' ' A' ' 55' ' ' LEU . 6.0 m-30 -84.3 136.71 33.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.141 -0.974 . . . . 0.0 111.128 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.474 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -96.55 116.33 28.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.637 -0.664 . . . . 0.0 109.602 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.52 152.78 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER 61.52 135.38 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.307 -0.871 . . . . 0.0 110.472 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . 3.7 t -108.59 64.7 0.62 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -0.974 . . . . 0.0 110.277 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -138.34 132.27 16.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 110.377 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.55 -65.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.49 1.288 0 C-N-CA 123.079 -1.634 . . . . 0.0 110.227 -0.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.424 ' O ' ' CG2' ' A' ' 96' ' ' THR . 17.6 mt 51.6 71.91 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.39 -0.819 . . . . 0.0 110.627 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -161.22 -80.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 110.104 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.35 -23.4 63.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.974 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.98 -160.91 1.2 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 110.115 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.09 156.69 21.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 110.384 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -105.52 139.12 40.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.83 142.11 38.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.991 -1.068 . . . . 0.0 111.014 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.49 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 7.5 p90 -145.52 169.44 18.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.996 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.427 ' CD2' ' HA ' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -118.39 127.92 54.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 111.035 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.451 ' CD1' ' CG2' ' A' ' 119' ' ' VAL . 3.4 mt -95.35 111.92 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 108.861 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.511 ' CD2' ' CG ' ' A' ' 116' ' ' GLN . 97.4 m-85 -87.38 145.76 26.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.486 -0.759 . . . . 0.0 111.183 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.415 ' O ' ' CG ' ' A' ' 114' ' ' LYS . . . -130.19 147.09 51.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.598 -0.689 . . . . 0.0 109.363 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -147.9 113.57 5.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.967 -1.083 . . . . 0.0 110.858 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.452 ' HB2' ' CH2' ' A' ' 115' ' ' TRP . 21.1 t0 -87.65 113.55 23.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -71.56 -26.4 62.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.855 . . . . 0.0 110.008 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.02 -52.72 21.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.429 -0.794 . . . . 0.0 110.236 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.5 p -90.64 5.24 48.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.839 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 52.27 36.61 20.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.945 -1.097 . . . . 0.0 110.252 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.93 173.97 6.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 110.603 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 106' ' ' ALA . 15.7 tttt -156.09 148.85 24.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.355 -0.84 . . . . 0.0 110.222 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.496 ' CD1' ' HA3' ' A' ' 35' ' ' GLY . 12.8 m-90 -135.31 173.18 12.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 110.784 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.511 ' CG ' ' CD2' ' A' ' 105' ' ' TYR . 2.7 mt-30 -152.22 122.37 7.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.373 -0.829 . . . . 0.0 109.974 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG12 ' CE2' ' A' ' 36' ' ' PHE . 2.9 p -121.28 129.48 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.099 -1.001 . . . . 0.0 109.856 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 103' ' ' LEU . . . -89.07 117.02 27.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 111.249 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.49 ' HB ' ' CE1' ' A' ' 102' ' ' PHE . 70.8 t -101.45 129.85 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.392 -0.817 . . . . 0.0 109.296 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -114.88 118.25 32.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.161 -0.962 . . . . 0.0 111.22 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 121' ' ' LEU . 3.1 mm? -85.99 107.31 17.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.212 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.0 t -149.85 166.23 30.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.096 -1.002 . . . . 0.0 110.808 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -79.39 127.95 32.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.86 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -117.53 66.08 4.81 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 110.895 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.49 60.09 4.1 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.628 1.33 . . . . 0.0 110.356 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.0 m -82.82 137.08 34.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 110.564 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.0 mt -93.92 -19.86 20.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.407 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.4 m -51.51 116.65 2.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.525 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -115.58 35.95 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.285 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -136.09 79.95 42.79 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 110.429 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.91 137.98 43.02 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.663 1.349 . . . . 0.0 110.371 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -94.07 -67.42 0.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 110.34 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -136.15 39.4 2.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 110.491 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.425 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 0.1 OUTLIER -161.87 62.79 1.47 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.16 -0.963 . . . . 0.0 110.478 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 134' ' ' GLU . 26.9 Cg_exo -58.58 -61.2 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.655 1.345 . . . . 0.0 110.42 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -59.37 133.99 56.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.413 ' CG ' ' HG3' ' A' ' 139' ' ' GLU . 5.2 pt-20 -154.3 34.16 0.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.91 . . . . 0.0 110.485 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 138' ' ' ILE . 2.7 mp 52.33 33.94 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.68 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.413 ' HG3' ' CG ' ' A' ' 137' ' ' GLU . 3.4 mt-10 -123.21 -47.28 2.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.253 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 56.05 27.0 10.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.882 . . . . 0.0 110.444 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.1 mt -95.64 -67.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.932 . . . . 0.0 110.125 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.3 p -83.63 160.94 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 110.342 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.6 t80 52.58 85.16 0.2 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.326 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.04 175.94 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.678 1.357 . . . . 0.0 110.561 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.75 54.53 1.5 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.72 73.34 1.42 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.02 57.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.355 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.96 95.05 3.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.422 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -68.22 -43.45 77.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.0 110.412 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -55.33 119.05 4.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 88.7 p -116.17 -45.64 2.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.354 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.16 -163.64 12.45 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.11 110.72 22.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -1.144 . . . . 0.0 110.33 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.69 132.8 52.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.02 105.98 17.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -150.82 20.78 0.79 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.913 . . . . 0.0 110.437 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -28.89 65.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.274 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -138.42 175.78 9.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 110.374 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.41 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.252 0.549 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -170.28 31.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 110.373 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 m -128.27 -41.24 1.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.451 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.07 110.93 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.489 ' HG2' HG23 ' A' ' 29' ' ' ILE . 5.0 tt0 -133.08 -78.77 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -1.122 . . . . 0.0 110.146 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.489 HG23 ' HG2' ' A' ' 28' ' ' GLU . 26.6 pt -135.78 174.23 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.206 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.75 19.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 110.476 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 145.33 24.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.388 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.76 140.4 42.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 110.346 179.863 -157.878 -166.278 129.073 104.186 2.021 104.228 128.797 -151.184 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.02 93.49 4.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.502 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 m -74.05 125.5 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.263 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.517 ' HA3' ' CD1' ' A' ' 115' ' ' TRP . . . 128.5 -163.61 21.94 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.401 ' CD2' ' HB3' ' A' ' 115' ' ' TRP . 23.4 m-85 -85.6 160.19 53.95 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.282 -1.128 . . . . 0.0 109.922 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -86.81 33.7 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.597 1.314 . . . . 0.0 111.681 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.11 42.6 30.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.943 -1.098 . . . . 0.0 110.699 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -132.22 -159.21 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 110.003 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.593 HG12 ' HB3' ' A' ' 118' ' ' ALA . 12.3 m -141.45 151.72 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.094 -1.004 . . . . 0.0 110.543 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.428 ' CD2' HG21 ' A' ' 117' ' ' VAL . 22.7 m-85 -111.18 157.6 19.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.662 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.32 123.74 32.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.01 -1.057 . . . . 0.0 111.012 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.867 ' HB3' ' CD1' ' A' ' 121' ' ' LEU . . . -109.68 136.28 49.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.472 -0.767 . . . . 0.0 109.674 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.16 139.9 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 0.0 110.979 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.945 HD22 HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -131.38 152.21 80.12 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.545 -0.722 . . . . 0.0 109.517 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.456 ' HD2' HD23 ' A' ' 45' ' ' LEU . 18.6 Cg_endo -63.53 -15.75 50.47 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.467 1.246 . . . . 0.0 111.266 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 1.8 ttpm? 53.4 27.04 5.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.278 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.499 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 34.2 m-20 -121.71 32.56 5.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.154 -0.966 . . . . 0.0 110.388 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.407 HG23 ' C ' ' A' ' 48' ' ' ASP . 3.3 t 63.34 36.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.247 -0.908 . . . . 0.0 110.649 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.499 ' CD2' ' HB2' ' A' ' 48' ' ' ASP . 6.4 m-70 -96.22 121.64 38.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.004 -1.06 . . . . 0.0 110.164 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -84.68 -174.77 5.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.358 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 54.8 42.49 79.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.838 ' HG3' HD21 ' A' ' 45' ' ' LEU . 73.7 mm-40 -70.89 163.2 66.95 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.429 -1.042 . . . . 0.0 111.109 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 52.3 Cg_exo -54.18 175.84 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.99 1.521 . . . . 0.0 112.367 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.977 HD22 ' CG ' ' A' ' 88' ' ' TYR . 26.4 mt -113.58 129.83 56.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.768 -0.583 . . . . 0.0 110.349 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.785 HD12 ' HB2' ' A' ' 43' ' ' ALA . 1.2 tt -91.96 151.74 20.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.604 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 44.6 t-20 -128.32 122.04 30.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.916 . . . . 0.0 110.731 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 85' ' ' GLY . 30.0 m -86.34 153.9 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.178 -0.951 . . . . 0.0 109.819 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 62.66 2.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 110.763 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.46 ' CE1' ' HA2' ' A' ' 35' ' ' GLY . 76.1 t80 -57.68 120.64 8.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.982 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -68.78 128.16 35.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 110.065 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.28 158.96 15.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 110.788 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.419 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 2.0 t -174.11 -178.09 1.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.488 -0.758 . . . . 0.0 109.921 179.703 -151.184 128.797 129.073 104.228 2.021 104.186 -166.278 -157.878 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.12 -144.5 0.65 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.062 -1.024 . . . . 0.0 110.051 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -142.56 124.6 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.904 -1.122 . . . . 0.0 110.655 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 57.79 115.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.537 -0.727 . . . . 0.0 111.088 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 69' ' ' VAL . 1.8 ptp85 -156.91 70.43 0.63 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 110.367 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -68.47 114.96 7.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.022 -1.049 . . . . 0.0 110.112 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' A' ' 108' ' ' ASP . 12.0 m -108.56 165.53 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 110.415 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -92.63 144.83 24.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.199 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' CD2' ' HA ' ' A' ' 83' ' ' GLU . 37.9 m-85 -122.37 157.61 31.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.714 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.69 141.65 22.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.378 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.605 ' HB3' HG13 ' A' ' 81' ' ' VAL . 5.0 p -110.6 171.52 7.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -0.923 . . . . 0.0 110.455 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 t -159.35 35.73 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.482 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HG3' ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -92.63 144.6 28.94 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.342 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -50.91 -55.55 3.96 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.581 1.306 . . . . 0.0 110.503 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.708 ' HB1' ' HB3' ' A' ' 91' ' ' ARG . . . -61.32 -156.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' HB ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -103.75 125.64 50.35 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.372 -0.83 . . . . 0.0 109.595 178.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.583 ' HD2' HG22 ' A' ' 87' ' ' VAL . 8.4 m-85 -132.13 149.78 52.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.945 -1.097 . . . . 0.0 110.765 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 88' ' ' TYR . 16.9 mttt -129.61 111.94 13.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.634 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.605 HG13 ' HB3' ' A' ' 73' ' ' SER . 33.6 m -86.75 116.68 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.442 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.91 137.94 31.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.256 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' HA ' ' CD2' ' A' ' 71' ' ' TYR . 4.1 mt-10 -46.64 -26.76 0.97 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.569 -0.707 . . . . 0.0 110.973 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.68 -11.85 48.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 110.518 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.919 ' O ' HG22 ' A' ' 58' ' ' VAL . . . 98.65 31.11 6.51 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 8.4 p -122.4 112.89 18.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.235 . . . . 0.0 111.121 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG12 HD23 ' A' ' 56' ' ' LEU . 11.8 p -96.11 122.28 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.946 -1.096 . . . . 0.0 108.898 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.977 ' CG ' HD22 ' A' ' 55' ' ' LEU . 6.0 m-30 -84.3 136.71 33.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.141 -0.974 . . . . 0.0 111.128 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 54' ' ' PRO . . . -96.55 116.33 28.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.637 -0.664 . . . . 0.0 109.602 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.589 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 2.4 t -124.52 152.78 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.708 ' HB3' ' HB1' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 61.52 135.38 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.307 -0.871 . . . . 0.0 110.472 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.419 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . 3.7 t -108.59 64.7 0.62 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -0.974 . . . . 0.0 110.277 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -138.34 132.27 16.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 110.377 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.55 -65.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.49 1.288 0 C-N-CA 123.079 -1.634 . . . . 0.0 110.227 -0.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.945 HD13 HD22 ' A' ' 45' ' ' LEU . 17.6 mt 51.6 71.91 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.39 -0.819 . . . . 0.0 110.627 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -161.22 -80.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 110.104 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.35 -23.4 63.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.974 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.98 -160.91 1.2 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 110.115 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.09 156.69 21.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 110.384 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -105.52 139.12 40.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.83 142.11 38.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.991 -1.068 . . . . 0.0 111.014 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.649 ' HE2' HG21 ' A' ' 87' ' ' VAL . 7.5 p90 -145.52 169.44 18.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.996 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.801 HD22 ' HA ' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -118.39 127.92 54.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 111.035 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.607 ' CD1' HG21 ' A' ' 119' ' ' VAL . 3.4 mt -95.35 111.92 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 108.861 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.511 ' CD2' ' CG ' ' A' ' 116' ' ' GLN . 97.4 m-85 -87.38 145.76 26.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.486 -0.759 . . . . 0.0 111.183 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.415 ' O ' ' CG ' ' A' ' 114' ' ' LYS . . . -130.19 147.09 51.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.598 -0.689 . . . . 0.0 109.363 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -147.9 113.57 5.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.967 -1.083 . . . . 0.0 110.858 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.793 ' HA ' HG12 ' A' ' 69' ' ' VAL . 21.1 t0 -87.65 113.55 23.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -71.56 -26.4 62.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.855 . . . . 0.0 110.008 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.02 -52.72 21.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.429 -0.794 . . . . 0.0 110.236 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.5 p -90.64 5.24 48.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.839 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 52.27 36.61 20.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.945 -1.097 . . . . 0.0 110.252 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.93 173.97 6.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 110.603 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 106' ' ' ALA . 15.7 tttt -156.09 148.85 24.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.355 -0.84 . . . . 0.0 110.222 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.517 ' CD1' ' HA3' ' A' ' 35' ' ' GLY . 12.8 m-90 -135.31 173.18 12.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 110.784 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.511 ' CG ' ' CD2' ' A' ' 105' ' ' TYR . 2.7 mt-30 -152.22 122.37 7.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.373 -0.829 . . . . 0.0 109.974 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.428 HG21 ' CD2' ' A' ' 41' ' ' TYR . 2.9 p -121.28 129.48 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.099 -1.001 . . . . 0.0 109.856 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.801 ' HA ' HD22 ' A' ' 103' ' ' LEU . . . -89.07 117.02 27.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 111.249 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 104' ' ' ILE . 70.8 t -101.45 129.85 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.392 -0.817 . . . . 0.0 109.296 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -114.88 118.25 32.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.161 -0.962 . . . . 0.0 111.22 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.867 ' CD1' ' HB3' ' A' ' 43' ' ' ALA . 3.1 mm? -85.99 107.31 17.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.212 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.0 t -149.85 166.23 30.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.096 -1.002 . . . . 0.0 110.808 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -79.39 127.95 32.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.86 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -117.53 66.08 4.81 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 110.895 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.49 60.09 4.1 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.628 1.33 . . . . 0.0 110.356 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.0 m -82.82 137.08 34.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 110.564 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.0 mt -93.92 -19.86 20.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.407 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.4 m -51.51 116.65 2.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.525 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.435 ' OE2' HG23 ' A' ' 142' ' ' VAL . 2.4 mm-40 -115.58 35.95 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -136.09 79.95 42.79 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 110.429 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.91 137.98 43.02 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.663 1.349 . . . . 0.0 110.371 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -94.07 -67.42 0.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 110.34 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -136.15 39.4 2.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 110.491 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.431 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 0.1 OUTLIER -161.87 62.79 1.47 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.16 -0.963 . . . . 0.0 110.478 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.431 ' HD3' ' N ' ' A' ' 134' ' ' GLU . 26.9 Cg_exo -58.58 -61.2 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.655 1.345 . . . . 0.0 110.42 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -59.37 133.99 56.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.409 ' CG ' ' HG3' ' A' ' 139' ' ' GLU . 5.2 pt-20 -154.3 34.16 0.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.91 . . . . 0.0 110.485 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 138' ' ' ILE . 2.7 mp 52.33 33.94 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.68 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.481 ' HB3' HD12 ' A' ' 141' ' ' ILE . 3.4 mt-10 -123.21 -47.28 2.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.253 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 56.05 27.0 10.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.882 . . . . 0.0 110.444 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 139' ' ' GLU . 57.1 mt -95.64 -67.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.932 . . . . 0.0 110.125 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.435 HG23 ' OE2' ' A' ' 129' ' ' GLU . 8.3 p -83.63 160.94 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 110.342 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.6 t80 52.58 85.16 0.2 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.326 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.04 175.94 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.678 1.357 . . . . 0.0 110.561 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.75 54.53 1.5 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.72 73.34 1.42 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.02 57.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.355 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.96 95.05 3.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.422 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -68.22 -43.45 77.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.0 110.412 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -55.33 119.05 4.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 88.7 p -116.17 -45.64 2.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.354 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.16 -163.64 12.45 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.11 110.72 22.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -1.144 . . . . 0.0 110.33 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.69 132.8 52.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.02 105.98 17.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -150.82 20.78 0.79 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.913 . . . . 0.0 110.437 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -28.89 65.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.274 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -138.42 175.78 9.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 110.374 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.41 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.252 0.549 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -170.28 31.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 110.373 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 m -128.27 -41.24 1.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.451 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.07 110.93 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.489 ' HG2' HG23 ' A' ' 29' ' ' ILE . 5.0 tt0 -133.08 -78.77 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -1.122 . . . . 0.0 110.146 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.489 HG23 ' HG2' ' A' ' 28' ' ' GLU . 26.6 pt -135.78 174.23 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.206 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.75 19.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.885 . . . . 0.0 110.476 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 145.33 24.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.388 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.0 t -75.76 140.4 42.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 110.346 179.863 -157.878 -166.278 129.073 104.186 2.021 104.228 128.797 -151.184 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.02 93.49 4.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.502 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.3 m -74.05 125.5 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 110.263 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.517 ' HA3' ' CD1' ' A' ' 115' ' ' TRP . . . 128.5 -163.61 21.94 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.401 ' CD2' ' HB3' ' A' ' 115' ' ' TRP . 23.4 m-85 -85.6 160.19 53.95 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.282 -1.128 . . . . 0.0 109.922 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -86.81 33.7 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.597 1.314 . . . . 0.0 111.681 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.11 42.6 30.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.943 -1.098 . . . . 0.0 110.699 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -132.22 -159.21 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 110.003 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.593 HG12 ' HB3' ' A' ' 118' ' ' ALA . 12.3 m -141.45 151.72 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.094 -1.004 . . . . 0.0 110.543 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.428 ' CD2' HG21 ' A' ' 117' ' ' VAL . 22.7 m-85 -111.18 157.6 19.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.662 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.32 123.74 32.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.01 -1.057 . . . . 0.0 111.012 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.867 ' HB3' ' CD1' ' A' ' 121' ' ' LEU . . . -109.68 136.28 49.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.472 -0.767 . . . . 0.0 109.674 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.16 139.9 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 0.0 110.979 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.945 HD22 HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -131.38 152.21 80.12 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.545 -0.722 . . . . 0.0 109.517 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.456 ' HD2' HD23 ' A' ' 45' ' ' LEU . 18.6 Cg_endo -63.53 -15.75 50.47 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.467 1.246 . . . . 0.0 111.266 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 96' ' ' THR . 1.8 ttpm? 53.4 27.04 5.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.278 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.499 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 34.2 m-20 -121.71 32.56 5.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.154 -0.966 . . . . 0.0 110.388 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.407 HG23 ' C ' ' A' ' 48' ' ' ASP . 3.3 t 63.34 36.7 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.247 -0.908 . . . . 0.0 110.649 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.499 ' CD2' ' HB2' ' A' ' 48' ' ' ASP . 6.4 m-70 -96.22 121.64 38.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.004 -1.06 . . . . 0.0 110.164 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -84.68 -174.77 5.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.358 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 54.8 42.49 79.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.838 ' HG3' HD21 ' A' ' 45' ' ' LEU . 73.7 mm-40 -70.89 163.2 66.95 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.429 -1.042 . . . . 0.0 111.109 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 52.3 Cg_exo -54.18 175.84 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.99 1.521 . . . . 0.0 112.367 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.977 HD22 ' CG ' ' A' ' 88' ' ' TYR . 26.4 mt -113.58 129.83 56.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.768 -0.583 . . . . 0.0 110.349 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.785 HD12 ' HB2' ' A' ' 43' ' ' ALA . 1.2 tt -91.96 151.74 20.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.604 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 44.6 t-20 -128.32 122.04 30.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.916 . . . . 0.0 110.731 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 85' ' ' GLY . 30.0 m -86.34 153.9 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.178 -0.951 . . . . 0.0 109.819 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 62.66 2.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 110.763 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.46 ' CE1' ' HA2' ' A' ' 35' ' ' GLY . 76.1 t80 -57.68 120.64 8.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.982 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -68.78 128.16 35.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 110.065 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.28 158.96 15.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 110.788 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.419 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 2.0 t -174.11 -178.09 1.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.488 -0.758 . . . . 0.0 109.921 179.703 -151.184 128.797 129.073 104.228 2.021 104.186 -166.278 -157.878 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.12 -144.5 0.65 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.062 -1.024 . . . . 0.0 110.051 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -142.56 124.6 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.904 -1.122 . . . . 0.0 110.655 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.5 mttt 57.79 115.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.537 -0.727 . . . . 0.0 111.088 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 69' ' ' VAL . 1.8 ptp85 -156.91 70.43 0.63 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 110.367 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -68.47 114.96 7.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.022 -1.049 . . . . 0.0 110.112 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' A' ' 108' ' ' ASP . 12.0 m -108.56 165.53 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 110.415 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -92.63 144.83 24.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.199 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' CD2' ' HA ' ' A' ' 83' ' ' GLU . 37.9 m-85 -122.37 157.61 31.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.714 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.69 141.65 22.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.378 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.605 ' HB3' HG13 ' A' ' 81' ' ' VAL . 5.0 p -110.6 171.52 7.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -0.923 . . . . 0.0 110.455 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 t -159.35 35.73 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.482 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HG3' ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -92.63 144.6 28.94 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.342 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -50.91 -55.55 3.96 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.581 1.306 . . . . 0.0 110.503 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.708 ' HB1' ' HB3' ' A' ' 91' ' ' ARG . . . -61.32 -156.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' HB ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -103.75 125.64 50.35 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.372 -0.83 . . . . 0.0 109.595 178.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.583 ' HD2' HG22 ' A' ' 87' ' ' VAL . 8.4 m-85 -132.13 149.78 52.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.945 -1.097 . . . . 0.0 110.765 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 88' ' ' TYR . 16.9 mttt -129.61 111.94 13.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.634 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.605 HG13 ' HB3' ' A' ' 73' ' ' SER . 33.6 m -86.75 116.68 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.442 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.91 137.94 31.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 110.256 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' HA ' ' CD2' ' A' ' 71' ' ' TYR . 4.1 mt-10 -46.64 -26.76 0.97 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.569 -0.707 . . . . 0.0 110.973 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.68 -11.85 48.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 110.518 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.919 ' O ' HG22 ' A' ' 58' ' ' VAL . . . 98.65 31.11 6.51 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 8.4 p -122.4 112.89 18.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.235 . . . . 0.0 111.121 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG12 HD23 ' A' ' 56' ' ' LEU . 11.8 p -96.11 122.28 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.946 -1.096 . . . . 0.0 108.898 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.977 ' CG ' HD22 ' A' ' 55' ' ' LEU . 6.0 m-30 -84.3 136.71 33.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.141 -0.974 . . . . 0.0 111.128 -176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 54' ' ' PRO . . . -96.55 116.33 28.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.637 -0.664 . . . . 0.0 109.602 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.589 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 2.4 t -124.52 152.78 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.708 ' HB3' ' HB1' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 61.52 135.38 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.307 -0.871 . . . . 0.0 110.472 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.419 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . 3.7 t -108.59 64.7 0.62 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -0.974 . . . . 0.0 110.277 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -138.34 132.27 16.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 110.377 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.55 -65.11 0.03 OUTLIER 'Cis proline' 0 N--CA 1.49 1.288 0 C-N-CA 123.079 -1.634 . . . . 0.0 110.227 -0.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.945 HD13 HD22 ' A' ' 45' ' ' LEU . 17.6 mt 51.6 71.91 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.39 -0.819 . . . . 0.0 110.627 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -161.22 -80.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 110.104 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.35 -23.4 63.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.974 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.98 -160.91 1.2 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 110.115 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.09 156.69 21.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 110.384 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -105.52 139.12 40.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.83 142.11 38.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.991 -1.068 . . . . 0.0 111.014 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.649 ' HE2' HG21 ' A' ' 87' ' ' VAL . 7.5 p90 -145.52 169.44 18.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.996 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.801 HD22 ' HA ' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -118.39 127.92 54.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 111.035 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.607 ' CD1' HG21 ' A' ' 119' ' ' VAL . 3.4 mt -95.35 111.92 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.932 . . . . 0.0 108.861 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.511 ' CD2' ' CG ' ' A' ' 116' ' ' GLN . 97.4 m-85 -87.38 145.76 26.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.486 -0.759 . . . . 0.0 111.183 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.415 ' O ' ' CG ' ' A' ' 114' ' ' LYS . . . -130.19 147.09 51.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.598 -0.689 . . . . 0.0 109.363 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -147.9 113.57 5.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.967 -1.083 . . . . 0.0 110.858 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.793 ' HA ' HG12 ' A' ' 69' ' ' VAL . 21.1 t0 -87.65 113.55 23.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -71.56 -26.4 62.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.855 . . . . 0.0 110.008 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.02 -52.72 21.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.429 -0.794 . . . . 0.0 110.236 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.5 p -90.64 5.24 48.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.839 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 52.27 36.61 20.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.945 -1.097 . . . . 0.0 110.252 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -113.93 173.97 6.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 110.603 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 106' ' ' ALA . 15.7 tttt -156.09 148.85 24.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.355 -0.84 . . . . 0.0 110.222 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.517 ' CD1' ' HA3' ' A' ' 35' ' ' GLY . 12.8 m-90 -135.31 173.18 12.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 110.784 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.511 ' CG ' ' CD2' ' A' ' 105' ' ' TYR . 2.7 mt-30 -152.22 122.37 7.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.373 -0.829 . . . . 0.0 109.974 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.428 HG21 ' CD2' ' A' ' 41' ' ' TYR . 2.9 p -121.28 129.48 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.099 -1.001 . . . . 0.0 109.856 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.801 ' HA ' HD22 ' A' ' 103' ' ' LEU . . . -89.07 117.02 27.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.962 . . . . 0.0 111.249 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 104' ' ' ILE . 70.8 t -101.45 129.85 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.392 -0.817 . . . . 0.0 109.296 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -114.88 118.25 32.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.161 -0.962 . . . . 0.0 111.22 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.867 ' CD1' ' HB3' ' A' ' 43' ' ' ALA . 3.1 mm? -85.99 107.31 17.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.212 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.0 t -149.85 166.23 30.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.096 -1.002 . . . . 0.0 110.808 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -79.39 127.95 32.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.86 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -117.53 66.08 4.81 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 110.895 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.49 60.09 4.1 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.628 1.33 . . . . 0.0 110.356 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.0 m -82.82 137.08 34.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.912 . . . . 0.0 110.564 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.0 mt -93.92 -19.86 20.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.407 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.4 m -51.51 116.65 2.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 110.525 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.435 ' OE2' HG23 ' A' ' 142' ' ' VAL . 2.4 mm-40 -115.58 35.95 4.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.285 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -136.09 79.95 42.79 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 110.429 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.91 137.98 43.02 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.663 1.349 . . . . 0.0 110.371 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -94.07 -67.42 0.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 110.34 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -136.15 39.4 2.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 110.491 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.431 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 0.1 OUTLIER -161.87 62.79 1.47 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.16 -0.963 . . . . 0.0 110.478 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.431 ' HD3' ' N ' ' A' ' 134' ' ' GLU . 26.9 Cg_exo -58.58 -61.2 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.655 1.345 . . . . 0.0 110.42 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -59.37 133.99 56.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.409 ' CG ' ' HG3' ' A' ' 139' ' ' GLU . 5.2 pt-20 -154.3 34.16 0.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.91 . . . . 0.0 110.485 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 138' ' ' ILE . 2.7 mp 52.33 33.94 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.68 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.481 ' HB3' HD12 ' A' ' 141' ' ' ILE . 3.4 mt-10 -123.21 -47.28 2.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.253 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 56.05 27.0 10.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.882 . . . . 0.0 110.444 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 139' ' ' GLU . 57.1 mt -95.64 -67.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.932 . . . . 0.0 110.125 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.435 HG23 ' OE2' ' A' ' 129' ' ' GLU . 8.3 p -83.63 160.94 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 110.342 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.6 t80 52.58 85.16 0.2 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 110.326 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.04 175.94 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.678 1.357 . . . . 0.0 110.561 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.75 54.53 1.5 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -140.72 73.34 1.42 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.36 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.02 57.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.355 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.96 95.05 3.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 110.422 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -68.22 -43.45 77.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.0 110.412 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -55.33 119.05 4.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 88.7 p -116.17 -45.64 2.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 110.354 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.16 -163.64 12.45 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.11 110.72 22.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -1.144 . . . . 0.0 110.33 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.69 132.8 52.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 110.394 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.02 105.98 17.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -150.82 20.78 0.79 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.913 . . . . 0.0 110.437 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.48 -28.89 65.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.274 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -138.42 175.78 9.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 110.374 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.41 179.93 . . . . . . . . 1 1 . 1 stop_ save_